APPLICATION
ANDA078922
TYPE
ANDA
ORIGINAL APPROVAL
2008-02-14
LATEST ACTION
2020-02-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ZIDOVUDINEDiscontinued
ZIDOVUDINE 300MG · TABLET · ORAL
Approval history
2020-02-12Labeling · Supplement 15 · standardAP
2015-06-26Labeling · Supplement 10 · standardAP
2015-06-26Labeling · Supplement 9 · standardAP
2012-03-30Labeling · Supplement 5AP
2011-03-02Labeling · Supplement 4AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.